Ming Wu

2.1k citations

44 papers · 1.5k indexed · 1 hit paper · h-index 19

Impact in

Biochemistry top 2%
- Blood transfusion and management
Nephrology top 2%
- Renal Diseases and Glomerulopathies

Papers in ⓘ

Nephrology 15
- Chronic Kidney Disease and Diabetes 9
- Renal Diseases and Glomerulopathies 7
- Acute Kidney Injury Research 5
Biological Psychiatry 1

Co-authors: Rudolf P. Wüthrich (6 shared papers)Changlin Mei (13 shared papers)Lili Fu (4 shared papers)Qing Yao (2 shared papers)Dongping Chen (3 shared papers)Lijun Sun (1 shared paper)Rongrong Bian (1 shared paper)Lin Li (1 shared paper)
Journals: Kidney & Blood Pressure Research (5 papers)Scientific Reports (3 papers)American Journal of Physiology-Renal Physiology (3 papers)Renal Failure (2 papers)Advanced Science (2 papers)
Partner nations: China Switzerland South Korea

In The Last Decade

Ming Wu

42 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease 2017 · 590 citations

Peers

Countries citing papers authored by Ming Wu

Since Specialization

Citations

This map shows the geographic impact of Ming Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Wu more than expected).

Fields of papers citing papers by Ming Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Wu. The network helps show where Ming Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside Ming Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming Wu Line = papers co-authored together Ming Wu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease Kidney & Blood Pressure Research ·Qing Yao, Ming Wu, Jie Zhou, Zhou Meiyang, Dongping Chen, Lili Fu, Rongrong Bian, Xiaohong Xing, Lijun Sun, Xiaohong Hu, Lin Li, Bing Dai, Rudolf P. Wüthrich, Yiyi Ma, Changlin Mei Hit paper breakdown →	2017	590
2	Everolimus Retards Cyst Growth and Preserves Kidney Function in a Rodent Model for Polycystic Kidney Disease Kidney & Blood Pressure Research ·Ming Wu, Patricia R. Wahl, Michel Le Hir, Ying Wäckerle-Men, Rudolf P. Wüthrich, Andreas L. Serra	2007	99
3	A Curcumin‐Modified Coordination Polymers with ROS Scavenging and Macrophage Phenotype Regulating Properties for Efficient Ulcerative Colitis Treatment Advanced Science ·Hang Yao, Feifei Wang, Hui Chong, Jingjing Wang, Yang Bai, Meng Du, Xiaohui Yuan, Xiaofei Yang, Ming Wu, Yuping Li, Huan Pang	2023	77
4	Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m6A abrogation in RNA Journal of Biological Chemistry ·Peihui Zhou, Ming Wu, Chaoyang Ye, Qingqing Xu, Li Wang	2019	62
5	Differential expression of p38 MAPK α, β, γ, δ isoforms in nucleus pulposus modulates macrophage polarization in intervertebral disc degeneration Scientific Reports ·Chen Yang, Peng Cao, Yang Gao, Ming Wu, Yun Lin, Ye Tian, Wen Yuan	2016	60
6	Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI Theranostics ·Bojun Li, Yuqi Xia, Shuqin Mei, Zehua Ye, Baofeng Song, Xinzhou Yan, Fangyou Lin, Ting Rao, Weimin Yu, Changlin Mei, Jiayi Lv, Ming Wu, Zhiguo Mao, Xiangjun Zhou, Cheng Fan	2023	57
7	Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation Nephrology Dialysis Transplantation ·Ming Wu, Junhui Gu, Shuqin Mei, Dechao Xu, Ying Jing, Qing Yao, Meihan Chen, Ming Yang, Sixiu Chen, Bo Yang, Na Qi, Huimin Hu, Rudolf P. Wüthrich, Changlin Mei	2016	50
8	The long non-coding RNA MALAT1 is increased in renal ischemia-reperfusion injury and inhibits hypoxia-induced inflammation Renal Failure ·Hongyan Tian, Ming Wu, Peihui Zhou, Chuiguo Huang, Chaoyang Ye, Li Wang	2018	50
9	Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis Kidney & Blood Pressure Research ·Junhui Gu, Ming Yang, Na Qi, Shuqin Mei, Jiejian Chen, Shuwei Song, Ying Jing, Meihan Chen, Liangliang He, Lijun Sun, Huimin Hu, Lin Li, Rudolf P. Wüthrich, Ming Wu, Changlin Mei	2016	49
10	A novel pneumatic micropipette aspiration method using a balance pressure model Review of Scientific Instruments ·Qili Zhao, Ming Wu, Maosheng Cui, Yanding Qin, Jin Yu, Mingzhu Sun, Xin Zhao, Xizeng Feng	2013	37
11	Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease Science Advances ·Yongzhan Sun, Zhiheng Liu, Xinyi Cao, Yi Lu, Zeyun Mi, Chaoran He, Jing Liu, Zhanye Zheng, Mulin Jun Li, Tiegang Li, Dechao Xu, Ming Wu, Ying Cao, Yuhao Li, Baoxue Yang, Changlin Mei, Lirong Zhang, Yupeng Chen	2019	34
12	Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and glomerular hypertrophy in rat polycystic kidney disease American Journal of Physiology-Renal Physiology ·Ming Wu, Alexandre Arcaro, Zsuzsanna Varga, Alexander Vogetseder, Michel Le Hir, Rudolf P. Wüthrich, Andreas L. Serra	2009	29
13	Emodin ameliorates tubulointerstitial fibrosis in obstructed kidneys by inhibiting EZH2 Biochemical and Biophysical Research Communications ·Lin Xu, Jiandong Gao, Di Huang, Pinglan Lin, Dongsheng Yao, Feng Yang, Yaheng Zhang, Xuejun Yang, Ming Wu, Chaoyang Ye	2020	26
14	Genetically engineered nanovesicles mobilize synergistic antitumor immunity by ADAR1 silence and PDL1 blockade Molecular Therapy ·Lei Ding, Xiaolong Zhang, Peiwen Yu, Peng Fang, Yupeng Sun, Yanni Wu, Zijin Luo, Hongsheng Li, Yongyi Zeng, Ming Wu, Xiaolong Liu	2023	25
15	Reduced asymmetric dimethylarginine accumulation through inhibition of the type I protein arginine methyltransferases promotes renal fibrosis in obstructed kidneys The FASEB Journal ·Ming Wu, Pinglan Lin, Li Lin, Dongping Chen, Xuejun Yang, Lin Xu, Bing Zhou, Chen Wang, Yuanyuan Zhang, Cheng Luo, Chaoyang Ye	2019	23
16	Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway American Journal of Physiology-Renal Physiology ·Ying Jing, Ming Wu, Di Zhang, Dongping Chen, Ming Yang, Shuqin Mei, Liangliang He, Junhui Gu, Na Qi, Lili Fu, Li Lin, Changlin Mei	2018	21
17	Yes-Associated Protein (Yap) Is Necessary for Ciliogenesis and Morphogenesis during Pronephros Development in Zebrafish (Danio Rerio) International Journal of Biological Sciences ·Liangliang He, Wenyan Xu, Ying Jing, Ming Wu, Shuwei Song, Ying Cao, Changlin Mei	2015	20
18	The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China Kidney Diseases ·Cheng Xue, Chenchen Zhou, Ming Wu, Changlin Mei	2016	20
19	Salvianolic acid B attenuates tubulointerstitial fibrosis by inhibiting EZH2 to regulate the PTEN/Akt pathway Pharmaceutical Biology ·Pinglan Lin, Furong Qiu, Ming Wu, Lin Xu, Di Huang, Chen Wang, Xuejun Yang, Chaoyang Ye	2022	20
20	The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1 American Journal of Physiology-Renal Physiology ·Ming Wu, Meihan Chen, Ying Jing, Junhui Gu, Shuqin Mei, Qing Yao, Jie Zhou, Ming Yang, Lijun Sun, Wutao Wang, Huimin Hu, Rudolf P. Wüthrich, Changlin Mei	2016	17

About Ming Wu

Ming Wu is a scholar working on Nephrology, Biological Psychiatry, Genetics, Molecular Biology and Geriatrics and Gerontology, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Genetic and Kidney Cyst Diseases (10 papers), Chronic Kidney Disease and Diabetes (9 papers), Renal and related cancers (8 papers), Renal Diseases and Glomerulopathies (7 papers), Acute Kidney Injury Research (5 papers), Renal cell carcinoma treatment (4 papers), Renal and Vascular Pathologies (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Biochemistry (215 citations), Nephrology (222 citations), Critical Care and Intensive Care Medicine (85 citations), Internal Medicine (61 citations) and Genetics (446 citations). Ming Wu has collaborated with scholars based in China, Switzerland and South Korea. Frequent co-authors include Rudolf P. Wüthrich, Changlin Mei, Lili Fu, Qing Yao, Dongping Chen, Lijun Sun, Rongrong Bian, Lin Li, Xiaohong Hu and Xiaohong Xing. Their work appears in journals such as Kidney & Blood Pressure Research, Scientific Reports, American Journal of Physiology-Renal Physiology, Renal Failure and Advanced Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact